# A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes

> **NCT00400283** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 23 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** NNC 55-0414

## Key facts

- **NCT ID:** NCT00400283
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01-19
- **Primary completion:** 2001-05-03
- **Final completion:** 2001-05-03
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2017-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00400283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00400283, "A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00400283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*